Therapeutic stem cells encapsulated in a synthetic extracellular matrix selectively kill tumor cells, delay tumor growth, and increase survival in a mouse resection model of malignant glioma

Neurosurgery

Volumn 70, Issue 6, 2012, Pages

  Gursel, Demirkan B ^a   Berry, Nicholas ^a   Boockvar, John A ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CASPASE 7; FIREFLY LUCIFERASE; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

APOPTOSIS; ARTICLE; AUTOTRANSPLANTATION; BIOLUMINESCENCE; BLOOD BRAIN BARRIER; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CELL ENCAPSULATION; CELL MIGRATION; CELL VIABILITY; CLINICAL TRIAL (TOPIC); CYTOREDUCTIVE SURGERY; DRUG DELIVERY SYSTEM; DRUG HALF LIFE; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; FIBROBLAST; GLIOBLASTOMA; HUMAN; IN VITRO STUDY; MESENCHYMAL STEM CELL; NEURAL STEM CELL; NONHUMAN; PRIORITY JOURNAL; RISK REDUCTION; SURVIVAL RATE; TUMOR CELL; TUMOR GROWTH;

ANIMALS; BRAIN NEOPLASMS; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; DRUG CARRIERS; EXTRACELLULAR MATRIX; GLIOMA; MICE; NEURAL STEM CELLS; STEM CELL TRANSPLANTATION;

EID: 84861488419     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1227/01.neu.0000414945.71472.7d     Document Type: Article

References (15)

1. Muldoon LL, Soussain C, Jahnke K, et al. Chemotherapy delivery issues in central nervous system malignancy: A reality check. J Clin Oncol. 2007;25 (16):2295-2305.
2. Sarin H. Recent progress towards development of effective systemic chemotherapy for the treatment of malignant brain tumors. J Transl Med. 2009;7:77.
3. Corsten MF, Shah K. Therapeutic stem-cells for cancer treatment: hopes and hurdles in tactical warfare. Lancet Oncol. 2008;9(4):376-384.
4. Ehtesham M, Kabos P, Gutierrez MA, et al. Induction of glioblastoma apoptosis using neural stem cell-mediated delivery of tumor necrosis factorrelated apoptosis-inducing ligand. Cancer Res. 2002; 62(24):7170-7174.
5. Potter W, Kalil RE, Kao WJ. Biomimetic material systems for neural progenitor cell-based therapy. Front Biosci. 2008;13:806-821.
6. Pan L, Ren Y, Cui F, Xu Q. Viability and differentiation of neural precursors on hyaluronic acid hydrogen scaffold. J Neurosci Res. 2009;87(14): 3207-3220.
7. Kauer TM, Figueiredo JL, Hingtgen S, Shah K. Encapsulated therapeutic stem cells implanted in tumor resection cavity induce cell death in gliomas. Nat Neurosci. 2012;15(2):197-204.
8. Shah K. Mesenchymal stem cells engineered for cancer therapy [published online ahead of print]. Adv Drug Deliv Rev. 2011.
9. Akbar U, Jones T, Winestone J, et al. Delivery of temozolomide to the tumor bed via biodegradable gel matrices in a novel model of intracranial glioma with resection. J Neurooncol. 2009;94(2):203-212.
10. Rieger J, Naumann U, Glaser T, Ashkenazi A, Weller M. APO2 ligand: A novel lethal weapon against malignant glioma? FEBS Lett. 1998;427(1): 124-128.
11. Sheridan JP, Marsters SA, Pitti RM, et al. Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors. Science. 1997;277(5327):818-821.
12. Hingtgen SD, Kasmieh R, van de Water J, Weissleder R, Shah K. A novel molecule integrating therapeutic and diagnostic activities reveals multiple aspects of stem cell-based therapy. Stem Cells. 2010; 28(4):832-841.
13. Kim SM, Oh JH, Park SA, Ryu CH, et al. Irradiation enhances the tumor tropism and therapeutic potential of tumor necrosis factor-related apoptosis-inducing ligand-secreting human umbilical cord blood-derived mesenchymal stem cells in glioma therapy. Stem Cells. 2010;28(12):2217-2228.
14. Snyder EY. The risk of putting something where it does not belong: mesenchymal stem cells produce masses in the brain. Exp Neurol. 2011;230(1):75-77.
15. Mattis VB, Svendensen CN. Induced pluripotent stem cells: A new revolution for clinical neurology? Lancet Neurol. 2011;10(4):383-394